Literature DB >> 15614854

Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses.

Olivier Picone1, Jean-Marc Costa, Marianne Leruez-Ville, Pauline Ernault, Martine Olivi, Yves Ville.   

Abstract

OBJECTIVE: To assess the value of both cytomegalovirus (CMV) DNA quantification in amniotic fluid (AF) and CMV glycoprotein B (gB) genotype as prognostic factors in CMV congenital infection.
METHODS: Quantification of CMV DNA was performed prospectively by real-time PCR and gB genotypes were analysed by gene sequencing analysis in the amniotic fluid of 42 fetuses infected by CMV. These were correlated with clinical data on fetal anomalies and outcome.
RESULTS: The proportion of severely symptomatic fetuses was similar in each gB genotype group. Median CMV DNA load was higher in the group of symptomatic fetuses but this difference was not significant and high and low viral loads were found in both groups.
CONCLUSION: Neither gB genotype nor CMV DNA load in AF correlate with the severity of CMV congenital infection and these markers are unlikely to prove useful for the management of congenital infection. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15614854     DOI: 10.1002/pd.942

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  17 in total

Review 1.  Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature.

Authors:  Vera Seidel; Cornelia Feiterna-Sperling; Jan-Peter Siedentopf; Jörg Hofmann; Wolfgang Henrich; Christoph Bührer; Katharina Weizsäcker
Journal:  Med Microbiol Immunol       Date:  2017-07-21       Impact factor: 3.402

Review 2.  The "silent" global burden of congenital cytomegalovirus.

Authors:  Sheetal Manicklal; Vincent C Emery; Tiziana Lazzarotto; Suresh B Boppana; Ravindra K Gupta
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

3.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

4.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

5.  Diagnosis, gB genotype distribution and viral load of symptomatic congenitally infected CMV patients in Cuba.

Authors:  C Correa; V Kourí; L Pérez; Y Soto; C Limia
Journal:  J Perinatol       Date:  2016-06-16       Impact factor: 2.521

6.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

7.  Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples.

Authors:  T Goegebuer; B Van Meensel; K Beuselinck; V Cossey; M Van Ranst; M Hanssens; K Lagrou
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

8.  Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection.

Authors:  Aurélie Ducroux; Samira Cherid; Alexandra Benachi; Yves Ville; Marianne Leruez-Ville
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

9.  Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay.

Authors:  Xiaoli Pang; Atul Humar; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

10.  Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.

Authors:  K Lagrou; M Bodeus; M Van Ranst; P Goubau
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.